Exploring Wearable Technology and Lean Mass Alterations in GLP-1 Agonists, Bariatric Surgery, and Testosterone Replacement Therapy: Commentary. RPB 2025, 5 (1). https://doi.org/10.53520/rdpb2025.107140.